[EN] INFLAMMATORY DISEASE TREATMENT<br/>[FR] TRAITEMENT DE MALADIES INFLAMMATOIRES
申请人:PULMAGEN THERAPEUTICS INFLAMMATION LTD
公开号:WO2011098801A1
公开(公告)日:2011-08-18
Compounds of formula (I) are useful in the treatment of inflammatory disease wherein at least 95% by weight of the said compound of formula (I) is in the stereoconfiguration shown in formula (IA) and less than 5% by weight is in the stereoconfiguration shown in formula (IB) in which formulae (I), (IA) and (IB): R is CH3- or hydrogen; X1 is -OR1, -S(O)nR2 or -NR3R4 and X2 is-OH; or X1 and X2 taken together represent a radical *-OC(O)NH-** or *-C(O)N(H)O-** wherein the bond marked * is attached to the carbon to which W and R are attached, and the bond marked ** is attached to the carbonyl carbon; R1 and R2 are independently C1-6 alkyl optionally substituted with one or more halogen atoms; C1-6 alkoxyalkyl; or aryl R3 and R4 are independently hydrogen; C1-6 alkyl; aryl; a group -C(Ra)=C(Rb)-C(=O)-Ara wherein Ra and Rb are independently hydrogen or C1-6 alkyl and Ara is aryl; or a group -Arb-C(=O)-Arc wherein Arb and Arc are aryl; or -C(=O)O-Rc wherein Rc is an aryl or C1-6alkyl; or R3 and R4 taken together with the nitrogen to which they are attached form a saturated ring of 3 to 7 ring members or an unsaturated ring of 5 to 7 ring members; n is 0,1 or 2; W is a group which when linked to the -C(R)(X1)C(=O)X2 results in a compound (I) having PPARγ agonist activity.